English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1823]
News [2731]
Articles [202]
Editorials [1]
Conferences [136]
elearning [13]
Specific CD8 T cell states may indicate response to immune checkpoint therapy for melanoma
Specific CD8 T cell states may indicate response to immune checkpoint therapy for melanoma
Cold therapy offers promising prevention against taxane-induced dermatologic events
Cold therapy offers promising prevention against taxane-induced dermatologic events
UA targeting rhabdomyosarcoma, a rare paediatric cancer with few treatment options
UA targeting rhabdomyosarcoma, a rare paediatric cancer with few treatment options
Aggressive treatment for some stage IV lung cancer patients can dramatically improve OS
Aggressive treatment for some stage IV lung cancer patients can dramatically improve OS
Scientists neutralise reactive nitrogen molecules to enhance cancer immunotherapy
Scientists neutralise reactive nitrogen molecules to enhance cancer immunotherapy
New drug candidates reverse drug resistance in multiple myeloma in preclinical models
New drug candidates reverse drug resistance in multiple myeloma in preclinical models
Biologists discover source for boosting tumour cell drug sensitivity
Biologists discover source for boosting tumour cell drug sensitivity
ESMO 2018: Pregnancy may be possible after chemotherapy for breast cancer patients – but they may no longer wish to
ESMO 2018: Pregnancy may be possible after chemotherapy for breast cancer patients – but they may no longer wish to
Study shows surgery and radiation extend survival of patients with limited metastatic lung cancer
Study shows surgery and radiation extend survival of patients with limited metastatic lung cancer
ESMO 2018: Erlotinib improves progression-free survival in early mutated non-small cell lung cancer
ESMO 2018: Erlotinib improves progression-free survival in early mutated non-small cell lung cancer
<1...149150151152153...274>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top